Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genotype-phenotype correlations in FTDP-17: does form follow function?

Mark S Forman1

  • 1Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. formanm@mail.med.upenn.edu

Experimental Neurology
|May 18, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study.

Clinical pharmacology and therapeutics·2018
Same author

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients.

Science translational medicine·2016
Same author

Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man.

Scientific reports·2016
Same author

TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2010
Same author

VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.

The Journal of biological chemistry·2009
Same author

Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies.

Acta neuropathologica·2009
Same journal

PI3K/Akt pathway in ischemic stroke: A central regulator of neuronal survival and repair.

Experimental neurology·2026
Same journal

Hepatokines and stellakines in liver and neurological diseases: The liver-brain axis.

Experimental neurology·2026
Same journal

Structural dynamics of α-Synuclein: Multi-scale imaging insights into pathological progression across Synucleinopathies.

Experimental neurology·2026
Same journal

Retraction notice to 'Mitochondrial ferritin upregulation reduced oxidative stress and blood-brain-barrier disruption by maintaining cellular iron homeostasis in a neonatal rat model of germinal matrix hemorrhage' [Experimental Neurology 374 (2024) 114703].

Experimental neurology·2026
Same journal

Sivelestat sodium alleviates blood-brain barrier dysfunction after traumatic brain injury by reduction of NETs formation.

Experimental neurology·2026
Same journal

Corrigendum to "Primary and Immortalized Microglia Exhibit Divergent Responses to Hemoglobin" [Experimental Neurology 403 (2026) 115838].

Experimental neurology·2026
See all related articles